SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-19-000264
Filing Date
2019-02-07
Accepted
2019-02-07 16:15:18
Documents
2
Period of Report
2019-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. 8-K a51937655.htm 8-K 17322
2 EXHIBIT 99.1 a51937655ex99_1.htm EX-99.1 135220
  Complete submission text file 0001157523-19-000264.txt   153707
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 19575350
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1